Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treatment for Diabetic Neuropathy Using Repetitive Transcranial Magnetic Stimulation

NCT: NCT06482827 · COMPLETED

NCT IDNCT06482827
StatusCOMPLETED
Start Date2025-01-01
Completion2025-12-31

Brief Summary

The aim of this study is to determine whether a 4-week treatment of repetitive transcranial magnetic stimulation (rTMS) can alleviate the symptoms of neuropathy in individuals with diabetic neuropathy. The study will involve using questionnaires, nerve assessments, sensory tests, blood flow measurements, and blood tests to monitor any changes in symptoms after the rTMS intervention.

Frequently Asked Questions

What is Treatment for Diabetic Neuropathy Using Repetitive Transcranial Magnetic Stimulation?

Treatment for Diabetic Neuropathy Using Repetitive Transcranial Magnetic Stimulation is a clinical trial registered under NCT06482827. Current status: COMPLETED.

What is the status of NCT06482827?

The current status of NCT06482827 (Treatment for Diabetic Neuropathy Using Repetitive Transcranial Magnetic Stimulation) is: COMPLETED.

When did Treatment for Diabetic Neuropathy Using Repetitive Transcranial Magnetic Stimulation start?

Treatment for Diabetic Neuropathy Using Repetitive Transcranial Magnetic Stimulation started on 2025-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑